Vorinostat in combination with gemcitabine plus platinum in patients with advanced non-small-cell lung cancer: A phase I, dose-escalation study

被引：3
|
作者：
Misset, J.
Tredaniel, J.
Descourt, R.
Morot-Sibilot, D.
Zalcman, G.
Gachard, E.
Garcia-Vargas, J.
Rizvi, S.
Reiser, D.
Roben, L.
机构：
[1] Hop St Louis, Paris, France
[2] Inst Cancerol & Hematol, Brest, France
[3] DMAS Pneumol Oncol Thorac, Grenoble, France
[4] CHU Caen, F-14000 Caen, France
[5] MSD, Paris, France
[6] Merck Res Labs, Upper Gwynedd, PA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2008年 / 26卷 / 15期
关键词：
D O I：
10.1200/jco.2008.26.15_suppl.14601
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
14601
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Dose-Escalation Study of Thoracic Radiotherapy in Combination With Pemetrexed Plus Cisplatin Followed by Pemetrexed Consolidation Therapy in Japanese Patients With Locally Advanced Nonsquamous Non-Small-Cell Lung Cancer
    Niho, Seiji
    Kubota, Kaoru
    Nihei, Keiji
    Sekine, Ikuo
    Sumi, Minako
    Sekiguchi, Risa
    Funai, Jumpei
    Enatsu, Sotaro
    Ohe, Yuichiro
    Tamura, Tomohide
    CLINICAL LUNG CANCER, 2013, 14 (01) : 62 - 69
  • [32] Paclitaxel and carboplatin in combination with gemcitabine: A phase I-II trial in patients with advanced non-small-cell lung cancer
    Favaretto, A
    Ceresoli, GL
    Paccagnella, A
    Barbieri, F
    Bearz, A
    Ghiotto, C
    Oniga, F
    Schiavon, S
    Frustaci, S
    Villa, E
    ANNALS OF ONCOLOGY, 2000, 11 (11) : 1421 - 1426
  • [33] INTENSITY-MODULATED RADIOTHERAPY FOR LOCALLY ADVANCED NON-SMALL-CELL LUNG CANCER: A DOSE-ESCALATION PLANNING STUDY
    Lievens, Yolande
    Nulens, An
    Gaber, Mousa Amr
    Defraene, Gilles
    De Wever, Walter
    Stroobants, Sigrid
    Van den Heuvel, Frank
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 80 (01): : 306 - 313
  • [34] Phase I/IIa study of cetuximab with gemcitabine plus carboplatin in patients with chemotherapy-naive advanced non-small-cell lung cancer
    Robert, F
    Blumenschein, G
    Herbst, RS
    Fossella, FV
    Tseng, J
    Saleh, MN
    Needle, M
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (36) : 9089 - 9096
  • [35] Phase I study of ifosfamide plus high-dose epirubicin in advanced non-small-cell lung cancer
    Gridelli, C
    Rossi, A
    Incoronato, P
    Bruni, GS
    Scognamiglio, F
    Ruffolo, P
    Rinaldi, L
    Bianco, AR
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1996, 37 (06) : 613 - 615
  • [36] CONCURRENT CHEMORADIOTHERAPY WITH TOMOTHERAPY IN LOCALLY ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC): PHASE I, DOSE-ESCALATION STUDY
    Bearz, Alessandra
    Minatel, Emilio
    Abu Rumeileh, Imad
    Gobitti, Carlo
    Baresic, Tanja
    Drigo, Annalisa
    Talamini, Renato
    Vaccher, Emanuela
    Santarossa, Sandra
    Franchin, Gianni
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S1553 - S1553
  • [37] A PHASE I, DOSE-ESCALATION STUDY TO DETERMINE THE MAXIMUM TOLERATED DOSE OF ERLOTINIB WHEN COMBINED WITH PERTUZUMAB IN PREVIOUSLY TREATED NON-SMALL-CELL LUNG CANCER PATIENTS
    Felip, E.
    Ranson, M.
    Cedres, S.
    Dean, E.
    De Droogh, E.
    Brewster, M.
    McNally, V.
    Ross, G.
    Galdermans, D.
    ANNALS OF ONCOLOGY, 2008, 19 : 102 - 102
  • [38] Phase I dose escalation study of the PKCi inhibitor aurothiomalate for advanced non-small-cell lung cancer, ovarian cancer, and pancreatic cancer
    Mansfield, Aaron S.
    Fields, Alan P.
    Jatoi, Aminah
    Qi, Yingwei
    Adjei, Alex A.
    Erlichman, Charles
    Molina, Julian R.
    ANTI-CANCER DRUGS, 2013, 24 (10) : 1079 - 1083
  • [39] Erlotinib in combination with pemetrexed for patients with advanced non-small-cell lung cancer (NSCLC): a phase I dose-finding study
    Ranson, M.
    Reck, M.
    Anthoney, A.
    Hanauske, A. -R
    Dean, E.
    Melezinek, I.
    Klingelschmitt, G.
    Kletzl, H.
    Blatter, J.
    Twelves, C.
    ANNALS OF ONCOLOGY, 2010, 21 (11) : 2233 - 2239
  • [40] Radiotherapy Dose-Escalation Protocol: Selection Bias in Locally Advanced Non-Small-Cell Lung Cancer (NSCLC)
    Roman, N. O.
    Orton, M.
    Baker, S.
    Chung, T.
    Good, R. A.
    Paul, K.
    Weiss, E.
    JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (09) : S295 - S296
12345